Latest News
-
PROOF in the Publishing: Slicing the Data on Pridopidine
Pridopidine has been tested as a potential HD treatment over decades. The large PROOF-HD trial did not meet its main goals, but its results are now published. Publication makes the full data available, helping the HD community learn from the study.
-
Lighting the way: A new biomarker for Huntingtonâs disease
A new biomarker reveals brain changes in early Huntington's disease.
-
Novel research technique suggests an antioxidant gene protects vulnerable neurons
Researchers use a new technique in an HD mouse to uncover a gene, Gpx6, that is protective to vulnerable neurons.
-
Building a Better Mouse(trap): A New Model of Huntingtonâs Disease
New mouse model gives insights into Huntington's disease
-
Taking new targets to the bank: the DNA repair protein âATMâ is overactive in Huntington's disease
HD causes the normally helpful protein "ATM" to get a little overzealous. Now we can look for drugs to settle it down
-
2015 Huntington's Disease Therapeutics Conference: Day 3
Day 3 of updates from the annual HD Therapeutics Conference in Palm Springs
-
2015 Huntington's Disease Therapeutics Conference: Day 2
Day 2 of updates from the annual HD Therapeutics Conference in Palm Springs
-
2015 Huntington's Disease Therapeutics Conference: Day 1
Day 1 of updates from the annual HD Therapeutics Conference in Palm Springs
-
Unlocking the Potential of Antibodies as a Therapy for Huntingtonâs Disease
Antibodies are known for their role in immunity, but researchers repurpose them in many ways. Can they be used in HD?